• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯手术切除是原发性结直肠癌的充分治疗方法。

Surgical excision alone is adequate treatment for primary colorectal cancer.

作者信息

Hind R, Rew D R, Johnson C D

机构信息

University Surgical Unit, Southampton General Hospital.

出版信息

Ann R Coll Surg Engl. 1992 Jan;74(1):63-7.

PMID:1736798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2497502/
Abstract

This debate examines the arguments for and against the proposal that surgical excision alone is adequate treatment for primary colorectal cancer. The arguments in favour are that the results from curative surgery are excellent and that despite many trials of adjuvant chemotherapy, radiotherapy and immunotherapy, the proposed benefits remain unproven. Recent improvements in surgical technique, particularly for dissection of rectal tumours, have shown the way towards further improvement using surgery alone, and it is clear from a national survey that technical factors related to individual surgeons play a large part in determining recurrence rates. With optimum primary treatment, surgical excision alone is indeed adequate therapy. The arguments against this motion are that although a considerable number of patients do survive with surgery, the 5-year survival rate is poor when there is extensive local invasion or lymphatic metastases. Surgery starts therapy by reducing the tumour load, but other modalities are required to destroy the cells which might subsequently develop into metastases. Trial results with adjuvant therapy are encouraging, although many contain too few patients. We cannot be content with the results of treatment of Dukes' Stage B and C tumours; more trials are needed to determine the best treatment for these patients.

摘要

本次辩论探讨了支持和反对仅通过手术切除作为原发性结直肠癌充分治疗方案的论据。支持该方案的论据是,根治性手术的效果极佳,而且尽管进行了许多辅助化疗、放疗和免疫治疗试验,但所宣称的益处仍未得到证实。手术技术最近有所改进,尤其是直肠肿瘤的解剖技术,这为仅通过手术进一步改善病情指明了方向,并且一项全国性调查清楚表明,与个体外科医生相关的技术因素在决定复发率方面起着很大作用。通过最佳的初始治疗,仅手术切除确实是充分的治疗方法。反对该提议的论据是,尽管相当数量的患者确实通过手术存活下来,但当存在广泛的局部侵犯或淋巴转移时,5年生存率很低。手术通过减少肿瘤负荷开始治疗,但还需要其他方式来消灭那些可能随后发展为转移灶的细胞。辅助治疗的试验结果令人鼓舞,尽管许多试验纳入的患者数量过少。我们不能满足于Dukes B期和C期肿瘤的治疗结果;需要更多试验来确定这些患者的最佳治疗方法。

相似文献

1
Surgical excision alone is adequate treatment for primary colorectal cancer.单纯手术切除是原发性结直肠癌的充分治疗方法。
Ann R Coll Surg Engl. 1992 Jan;74(1):63-7.
2
[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].[局部晚期非炎性乳腺癌的联合化疗及术前放疗治疗:120例患者的最新结果]
Cancer Radiother. 2004 Jun;8(3):155-67. doi: 10.1016/j.canrad.2004.01.001.
3
Role of adjuvant therapy in colorectal cancer.辅助治疗在结直肠癌中的作用。
Adv Intern Med. 1991;36:219-47.
4
[Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].[关于直肠癌术前和术后化疗的既定数据及实用建议]
Ann Chir. 1999;53(10):1011-8.
5
Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.日本根治性淋巴结清扫术对Dukes' B期和C期结直肠癌患者10年生存率的改善:一项17年的回顾性研究。
Oncol Rep. 2003 Jul-Aug;10(4):927-34.
6
Current treatment for colorectal cancer metastatic to the liver.目前针对转移性结直肠癌肝转移的治疗方法。
Eur J Surg Oncol. 1999 Oct;25(5):451-63. doi: 10.1053/ejso.1999.0679.
7
Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.口服氟嘧啶辅助化疗用于杜克B期结直肠癌的适应证及疗效
Anticancer Res. 2006 Jul-Aug;26(4B):3089-93.
8
Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.胰腺癌的手术及多模式治疗——基于未来多模式治疗理念的综述
Gan To Kagaku Ryoho. 1999 Jan;26(1):10-40.
9
Role of surgery in the patients with stage I and II primary gastric lymphoma.手术在Ⅰ期和Ⅱ期原发性胃淋巴瘤患者中的作用。
Hepatogastroenterology. 2003 May-Jun;50(51):877-82.
10
Adjuvant and neoadjuvant therapy for gastric cancer.胃癌的辅助治疗和新辅助治疗。
Semin Oncol. 1996 Jun;23(3):379-89.

引用本文的文献

1
Predictive value of IL-18 and IL-10 in the prognosis of patients with colorectal cancer.白细胞介素-18和白细胞介素-10对结直肠癌患者预后的预测价值。
Oncol Lett. 2019 Jul;18(1):713-719. doi: 10.3892/ol.2019.10338. Epub 2019 May 8.
2
Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.结直肠癌组织的质谱蛋白质表达谱与疾病的临床病理特征相关。
BMC Cancer. 2010 Aug 6;10:410. doi: 10.1186/1471-2407-10-410.
3
Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.应用 MALDI-TOF 质谱技术分析结直肠癌患者术后血清蛋白质表达谱的变化:一项初步的方法学研究。
World J Surg Oncol. 2010 Apr 26;8:33. doi: 10.1186/1477-7819-8-33.
4
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.纤溶酶原激活剂及其抑制剂对杜克B期和C期结直肠癌患者生存预后的影响
Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306.
5
Transanal local resection for benign and malignant rectal tumours.
Int J Colorectal Dis. 1995;10(2):112-6. doi: 10.1007/BF00341209.

本文引用的文献

1
Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture.大肠癌“根治性”手术后的局部复发:I. 总体情况。
Br J Surg. 1984 Jan;71(1):12-6. doi: 10.1002/bjs.1800710104.
2
Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
Cancer. 1984 Jan 1;53(1):1-8. doi: 10.1002/1097-0142(19840101)53:1<1::aid-cncr2820530102>3.0.co;2-l.
3
Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.晚期原发性结肠癌或直肠癌患者静脉注射与腹腔注射5-氟尿嘧啶的前瞻性随机试验。
Surgery. 1985 Sep;98(3):414-22.
4
A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.
Br J Surg. 1985 May;72(5):359-63. doi: 10.1002/bjs.1800720509.
5
Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II.直肠癌的术前放疗与手术。退伍军人管理局外科肿瘤学组II期试验。
Cancer. 1986 Jul 15;58(2):352-9. doi: 10.1002/1097-0142(19860715)58:2<352::aid-cncr2820580226>3.0.co;2-d.
6
Experimental chemotherapy and concepts related to the cell cycle.实验性化疗与细胞周期相关概念
Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Feb;49(2):335-55. doi: 10.1080/09553008514552581.
7
Anastomotic recurrence in large bowel cancer.大肠癌的吻合口复发
Br J Surg. 1987 Oct;74(10):873-8. doi: 10.1002/bjs.1800741003.
8
Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer.一项关于结直肠癌辅助使用5-氟尿嘧啶和左旋咪唑的随机试验的五年结果
Br J Surg. 1987 Jul;74(7):569-72. doi: 10.1002/bjs.1800740707.
9
Adjuvant therapy of colorectal cancer. Why we still don't know.
JAMA. 1988 Jun 24;259(24):3571-8.
10
Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study.大肠癌的辅助治疗:西南肿瘤协作组研究的长期结果
J Clin Oncol. 1988 Jun;6(6):947-54. doi: 10.1200/JCO.1988.6.6.947.